logo
New, possibly deadly virus found in Alabama animals. Here's what we know so far

New, possibly deadly virus found in Alabama animals. Here's what we know so far

Yahoo05-02-2025

A new animal-borne virus has been discovered in Alabama. But the creature that carries it can be found along parts of the Atlantic seaboard, as far north as southern Saskatchewan, Canada, as far south as the Gulf states and as far west as Kansas.
A group of researchers from the The University of Queensland in Australia have identified a new strain of henipavirus in North America, the first found in the continent.
'Henipaviruses have caused serious disease and death in people and animals in other regions,' Dr. Rhys Parry of the UQ School of Chemistry and Molecular Biosciences said in a release from the university.
This strain is called Camp Hill, named for the place near Auburn, Alabama, where four infected northern short-tailed shrews were caught in 2021.
'The discovery of a henipavirus in North America is highly significant, as it suggests these viruses may be more globally distributed than previously thought.," Parry said.
Here's what we know so far about the new illness.
The Alabama Department of Conservation and Natural Resources data shows these animals are also called:
Short-tailed Blarina.
Mole Shrew.
Large Short-tailed Shrew.
According to the National Park Service, these shrews are about 4 inches long and weigh about an ounce. They're insectivores in the same family of animals as moles, and they aren't rodents like mice or rats.
They spend most of their time underground or in leaf litter and use echolocation to move in the dark.
These shrews have venomous saliva that's enough to paralyze or kill some prey. Because the shrew doesn't have fangs, it introduces the neurotoxin by chewing or gnawing on its intended victim.
What to know about Journavx: FDA approves new pain medication as an alternative to opioids
'The closest known henipavirus to Camp Hill virus that has caused disease in humans is Langya virus, which crossed from shrews to humans in China,' Parry said.
'This indicates that shrew-to-human transmission can occur.'
Shrews are considered the primary carrier for Langya, but it's also been found in goats and dogs.
"Given the high case-fatality rates associated with henipaviruses, detection of CHV in North America raises concerns about past and potential future spillover events. Further investigation is needed into the potential for human infection and strategies for mitigating transmission," reads the research letter published in Emerging Infectious Diseases.
'Henipaviruses have caused serious disease and death in people and animals in other regions,' Parry said.
He said the Hendra virus has a 70% fatality rate, and Nipah has "recorded fatality rates between 40 and 75 per cent in outbreaks in South-East Asia, including in Malaysia and Bangladesh."
They can cause respiratory distress and encephalitis.
No fatalities were reported from Langya, but infected people did reportedly have:
Fever.
Fatigue.
Cough.
Impaired liver or kidney funtion.
According to information from the CDC, henipaviruses are single-strand RNA viruses that can infect humans. Of six that were previously identified, "Hendra virus and Nipah virus are highly virulent emerging pathogens that cause outbreaks in humans and are associated with high case-fatality ratios."
The CDC has it listed as a travel-association infection primarily found in other countries:
Nipah virus: Southeast Asia and Bangladesh, India.
Hendra virus: Austrailia.
Langya virus: China.
Norovirus survival guide: How to get through the stomach flu
The CDC noted that travelers should avoid bat roosting areas and practice food safety to avoid food contaminated by infected animals.
Flying fox bats are known to be carriers, and horses exposed to bat urine can infect people.
More research was needed, according to the CDC, to see how Langya virus was transferred to humans from shrews.
Dr. Ariel Isaacs, who co-authored the research, said developing a vaccines for this virus family is an important next step in the UQ news release.
'The next step for this work is to characterise key surface proteins on the virus that are involved in cell entry to broaden our understanding of the virus family and identify better ways to protect against it,' Isaacs said.
The infected animals also carried Camp Ripley Virus, a hantavirus previously found in northern short-tailed shrews.
Hantavirus is commonly carried by rodents and can be spread to people via infected urine, feces or saliva and can be made airborne while cleaning. According to the New York Department of Health, it can't be spread from person to person.
Hantavirus can be deadly with symptoms possibly showing up weeks after infection. Early symptoms can look like fever, fatigue and muscle pain. More advanced infections might include headache, diarrhea, dizziness and nausea/vomiting. The main issue is fluid buildup in the lungs.
It can be diagnosed with a blood test. Seek medical attention quickly if you have symptoms and think you've been exposed.
Bonnie Bolden is a Deep South Connect reporter with Gannett/USA Today. Email her at bbolden@gannett.com.
This article originally appeared on Montgomery Advertiser: New strain of possibly deadly virus found in Alabama wild animals

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

1 Underrated Reason to Buy This Market-Beating Stock
1 Underrated Reason to Buy This Market-Beating Stock

Yahoo

time5 days ago

  • Yahoo

1 Underrated Reason to Buy This Market-Beating Stock

Eli Lilly recently acquired a smaller biotech for its promising investigational pain medication. The company generates strong sales from products outside of diabetes and obesity care. Eli Lilly's portfolio, both within and outside its core area, makes the stock attractive. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) has been one of the top-performing healthcare megacap stocks of the past decade. And in more recent years, particularly over the past five, it's easy to point to the biggest factor driving Eli Lilly's run: The company's work in diabetes and, especially, the weight loss market. Eli Lilly is unquestionably one of the two leaders in this fast-growing field, and it appears to be gaining ground on its biggest competitor, Novo Nordisk. However, a recent move Eli Lilly made reveals an underrated reason why the stock has attractive prospects. Here's what investors should know. On May 27, Eli Lilly announced it would dish out $1 billion in cash to acquire SiteOne Therapeutics, a privately held biotech. The key asset from this transaction is STC-004, a mid-stage investigational non-opioid oral pain medicine. Though there are treatment options for chronic pain, non-opioid ones could become increasingly popular since opioid-based therapies often carry significant side effects. Meanwhile, this market is brand new. In January, Vertex Pharmaceuticals earned approval from the U.S. Food and Drug Administration for Journavx, the first non-opioid oral pain inhibitor. Eli Lilly is looking to make waves in this market with the acquisition of SiteOne Therapeutics. The transaction may or may not pan out. Perhaps STC-004 will flop in upcoming clinical trials. But there's something important to highlight about Eli Lilly that this acquisition brings to light. This move is hardly out of the ordinary for Eli Lilly. One thing that sets it apart from Novo Nordisk is that, while the latter generates more than 90% of its revenue from its diabetes or obesity medicines, Eli Lilly's lineup of drugs features some major blockbusters outside this area. In the first quarter, the company's revenue grew 45% year over year to $12.73 billion. Eli Lilly's cancer drug Verzenio racked up $1.2 billion in sales, up 10% year over year. The company's immunosuppressant, Taltz, generated $762 million in revenue, a 26% increase over the year-ago period. Eli Lilly's sales outside of diabetes and obesity products accounted for almost 28% of its top line. That might not exactly be peak diversification, but Eli Lilly fares better than its eternal rival, Novo Nordisk, in this department. Furthermore, the company's newer products also feature several that fall outside its core area of expertise. These include Kisunla in Alzheimer's disease, Jaypirca in oncology, and Ebglyss, an eczema treatment. The same can be said about Eli Lilly's pipeline. Consider the company's investigational gene therapy for genetic deafness, as well as its several dozen programs in oncology. To be clear, Eli Lilly's diabetes and weight management medicines should continue occupying the role of main growth drivers. In the first quarter, Mounjaro's revenue soared by 113% year over year to $3.8 billion. Zepbound's sales came in at $2.3 billion, representing a 347% increase compared to the first quarter of 2024. Neither has peaked yet. Considering analyst projections for the GLP-1 market, they will continue growing their sales at an incredible clip at least through the end of the decade. And there is more where that came from, too. Eli Lilly is developing newer medicines in this area. The company's investigational oral GLP-1 therapy, orforglipron, recently aced a phase 3 study. According to management, the drugmaker has a total of 11 obesity pipeline candidates. So, Eli Lilly's work in this field will remain one of the major keys to its success. Perhaps it is what will get many investors nowadays interested in the stock. However, Eli Lilly is also a diversified pharmaceutical giant with a strong portfolio of medicines and promising candidates in oncology, immunology, and other areas. So, even with mounting competition in the GLP-1 market, Eli Lilly remains attractive, not just because it is likely to develop better anti-obesity medicines than most of its competitors, but because it is a leader in other markets as well. That's another excellent reason to invest in Eli Lilly and hold on to its shares for a long time. Before you buy stock in Eli Lilly, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Eli Lilly wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $657,385!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $842,015!* Now, it's worth noting Stock Advisor's total average return is 987% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Prosper Junior Bakiny has positions in Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Vertex Pharmaceuticals. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 1 Underrated Reason to Buy This Market-Beating Stock was originally published by The Motley Fool Sign in to access your portfolio

Hidden inland boulder is proof of massive tsunami that hit Tonga 7,000 years ago
Hidden inland boulder is proof of massive tsunami that hit Tonga 7,000 years ago

Miami Herald

time30-05-2025

  • Miami Herald

Hidden inland boulder is proof of massive tsunami that hit Tonga 7,000 years ago

On the island of Tongatapu, the main island of Tonga, researchers scoured the southern coastline for evidence of violent weather events that occurred thousands of years ago. They were specifically looking for boulders, as they can only be carried ashore or moved by massive waves in 'high-energy events, such as tsunamis or storms,' according to a May 14 study published in the journal Marine Geology. Aerial photo revealed several boulders, but the largest was hidden from view. Local farmers speaking with the researchers told them of a boulder deep inland atop a cliff, covered by dense vegetation that obscured it from aerial view, and led them to it. 'I was so surprised; it is located far inland outside of our field work area,' study author and Ph.D. candidate Martin Köhler said in a news release from The University of Queensland's School of the Environment. 'It was quite unbelievable to see this big piece of rock sitting there covered in and surrounded by vegetation,' Köhler said. Researchers said 7,000 years ago, a tsunami about 164 feet tall— the height of the Arc de Triomphe, or a giant sequoia — dislodged the enormous rock and moved it 656 feet inland. At 45 feet long, 22 feet tall, 39 feet wide and weighing 1,300 tons, the 'exceptional' Maka Lahi is the world's largest cliff-top boulder, according to the study. Models suggest the tsunami was triggered by a landslide caused by an earthquake near the Tonga-Kermadec Trench, according to the study. 'Understanding past extreme events is critical for hazard preparation and risk assessment now and in the future,' coastal geomorphologist Annie Lau said in the release. According to Lau, the region has a 'long history of tsunamis triggered by volcanic eruptions and earthquakes along the underwater Tofua Ridge and the Tonga Trench.' The research team included Martin Köhler, Annie Lau, Koki Nakata, Kazuhisa Goto, James Goff, Daniel Köhler, Mafoa Penisoni.

New Forest food waste bins ‘pose a danger to roaming pigs'
New Forest food waste bins ‘pose a danger to roaming pigs'

Yahoo

time28-05-2025

  • Yahoo

New Forest food waste bins ‘pose a danger to roaming pigs'

A row has broken out over the introduction of food waste bins to the New Forest amid claims that pigs will break into them and spread disease. Plastic caddies to recycle leftovers are being distributed to residents in the historic national park for the first time, but locals who have the right to graze animals have warned the bins pose a danger to livestock. The group of commoners said it was worried the roaming animals could eat the contents of the plastic receptacles and contract foot and mouth disease or African swine fever, which would be 'extremely dangerous'. Their comments came as authorities in Hampshire's New Forest welcomed a controversial wheelie bin scheme, which was first approved in 2022. Under the £5.6 million programme, food waste caddies are being delivered to residents in Brockenhurst, New Milton, Lymington and surrounding areas between April and June. Andrew Parry-Norton raised concerns at the Verderers' court, a historical body that 'regulates and protects the New Forest's unique agricultural commoning practices'. The chairman of the Commoners' Defence Association (CDA) said: 'New Forest district council is going to be supplying food waste bins for weekly collections. The advice is that these bins are left outside the gate, and then residents top them up from a smaller kitchen waste bin. 'In the UK, it is illegal to feed or allow kitchen waste to be fed to pigs. 'Not only could this be a problem for pigs, but also donkeys and ponies, who will quickly realise this could become a potential food source. 'We, the CDA, ask the verderers to persuade New Forest district council to retract their advice and request that these bins are kept on the residents' premises where stock [animals] do not have access to it.' Households in the national park have been given a 23-litre brown outdoor food waste recycling caddy and a five-litre grey indoor food waste recycling caddy. The council said food waste would be taken to an anaerobic digestion facility where it would be used to create fertiliser and renewable energy. Speaking after the meeting, Mr Parry-Norton said it was 'a good thing' that the council was looking at improving recycling rates. But he said: 'What they are recommending to the public is that they keep their waste food bins outside their gates. Now, I raised concerns about this. 'Obviously, we've got things like foot and mouth and African swine fever on the Continent, and that could come across in imported foods, harmless to humans, but obviously extremely dangerous to our animals, especially pigs. 'And so I raised concerns [that] our pigs could actually break these bins open and get hold of this waste food.' The commoner said he spoke with a councillor about the matter last week, who tried to 'assure me that it's very hard to get the lids off'. Mr Parry-Norton added: 'Well, to be honest with you, I don't think he's ever experienced a sow trying to get food out of the bin. She wouldn't take long to destroy a plastic tub – they're quite easy to get into.' The group of commoners – a body that is more than a thousand years old – is urging the council to retract the advice it has given to residents. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store